drugset

drugset / Trial / NCT06643299

Probiotic Use for Recovery Enhancement From Long COVID-19

NCT06643299 ↗

Phase 2 Active not recruiting 180 enrolled Rush University Medical Center

RandomizedCrossoverTriple-blindTreatment

Summary

The goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.

Timeline

Start: 2025-05-13
Primary completion: 2026-05
Completion: 2026-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	BlueBiology: Ultimate Care	Unknown	—	—

Indications